Дэвид Перлмуттер - Промывка мозга. Программа для ясного мышления, укрепления отношений с людьми и развития полезных привычек

J. J. Iliff et al. “A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β,” Sci. Transl. Med. 4, № 147 (August 2012): 147ra111.

L. Xie et al. “Sleep Drives Metabolite Clearance from the Adult Brain,” Science 342, № 6156 (October 2013): 373–377.

E. Shokri-Kojori et al. “β-Amyloid Accumulation in the Human Brain After One Night of Sleep Deprivation,” Proc. Natl. Acad. Sci. USA 115, № 17 (April 2018): 4483–4488.

P. Li et al. “Beta-Amyloid Deposition in Patients with Major Depressive Disorder with Differing Levels of Treatment Resistance: A Pilot Study,” EJNMMI Res. 7, № 1 (December 2017): 24; см. также S. Perin et al. “Amyloid Burden and Incident Depressive Symptoms in Preclinical Alzheimer’s Disease,” J. Affect. Disord. 229 (March 2018): 269–274.

E. Flores-Martinez and F. Peña-Ortega. “Amyloid β Peptide-Induced Changes in Prefrontal Cortex Activity and Its Response to Hippocampal Input,” Int. J. Pept. 12 (January 2017): 1–9.

B. T. Kress et al. “Impairment of Paravascular Clearance Pathways in the Aging Brain,” Ann. Neurol. 76, № 6 (December 2014): 845–861.

S. Yoo et al. “The Human Emotional Brain Without Sleep – A Prefrontal Amygdala Disconnect,” Curr. Biol. 17, № 20 (2007): 877–878.

Источник: Seung-Schik Yoo et al., Current Biology 17 (20): R877–8. October 2007.

E. van der Helm and M. P. Walker. “Overnight Therapy? The Role of Sleep in Emotional Brain Processing,” Psychol. Bull. 135, № 5 (September 2009): 731–748.

A. N. Goldstein and M. P. Walker. “The Role of Sleep in Emotional Brain Function,” Annu. Rev. Clin. Psychol. 10 (2014): 679–708.

Y. Motomura et al. “Two Days’ Sleep Debt Causes Mood Decline During Resting State via Diminished Amygdala-Prefrontal Connectivity,” Sleep 40, № 10 (October 2017).

E. Ben Simon and M. P. Walker. “Sleep Loss Causes Social Withdrawal and Loneliness,” Nat. Commun. 9, № 3146 (August 2018).

K. J. Brower and B. E. Perron. “Sleep Disturbance as a Universal Risk Factor for Relapse in Addictions to Psychoactive Substances,” Med. Hypotheses 74, № 5 (May 2010): 928–933.

Grand View Research. “Insomnia Therapeutics Market Analysis by Treatment Type [Devices, Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists)], by Sales Channel, and Segment Forecasts, 2018–2025,” October 2017. https://www.grandviewresearch.com/industry-analysis/insomnia-therapeutics-market.

Yinong Chong, Cheryl D. Fryar, and Quiping Gu. “Prescription Sleep Aid Use Among Adults: United States, 2005–2010,” Centers for Disease Control and Prevention, NCHS Data Brief 127, August 2013. https://www.cdc.gov/nchs/products/databriefs/db127.htm.

T. B. Huedo-Medina et al. “Effectiveness of Non-Benzodiazepine Hypnotics in Treatment of Adult Insomnia: Meta-Analysis of Data Submitted to the Food and Drug Administration,” BMJ 345 (December 2012): e8343.

D. F. Kripke, R. D. Langer, and L. E. Kline. “Hypnotics’ Association with Mortality or Cancer: A Matched Cohort Study,” BMJ Open 2 (2012): e000850.

D. F. Kripke. “Hypnotic Drug Risks of Mortality, Infection, Depression, and Cancer: But Lack of Benefit,” version 3, F1000Res. 5 (2016): 918.

Kripke. “Hypnotic Drug Risks.”

A. M. Chang et al. “Evening Use of Light-Emitting eReaders Negatively Affects Sleep, Circadian Timing, and Next-Morning Alertness,” Proc. Natl. Acad. Sci. USA 112, no. 4 (January 2015): 1232–1237.

J. M. Zeitzer et al. “Sensitivity of the Human Circadian Pacemaker to Nocturnal Light: Melatonin Phase Resetting and Suppression,” J. Physiol. 526, part 3 (August 2000): 695–702.

A. Garcia-Saenz et al. “Evaluating the Association Between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study),” Environ. Health Perspect. 126, № 4 (April 2018): 047011.

P. James et al. “Outdoor Light at Night and Breast Cancer Incidence in the Nurses’ Health Study II,” Environ. Health Perspect. 125, № 8 (August 2017): 087010.

T. A. Bedrosian and R. J. Nelson. “Timing of Light Exposure Affects Mood and Brain Circuits,” Transl. Psychiatry 7, № 1 (January 2017): e1017.

Common Sense Media. “The Common Sense Census: Media Use by Kids Age Zero to Eight 2017”. https://www.commonsensemedia.org/research/the-common-sense-census-media-use-by-kids-age-zero-to-eight-2017.

The National Sleep Foundation’s Sleep in America poll. https://www.sleepfoundation.org/sites/default/files/inline-files/Highlights_facts_06.pdf.

A. Shechter et al. “Blocking Nocturnal Blue Light for Insomnia: A Randomized Controlled Trial,” J. Psychiatr. Res. 96 (January 2018): 196–202.

F. H. Rångtell et al. “Two Hours of Evening Reading on a Self-Luminous Tablet vs. Reading a Physical Book Does Not Alter Sleep After Daytime Bright Light Exposure,” Sleep Med. 23 (July 2016): 111–118.

D. A. Raichlen and A. D. Gordon. “Relationship Between Exercise Capacity and Brain Size in Mammals,” PLoS One 6, № 6 (June 2011): e20601; см. также D. A. Raichlen and J. D. Polk. “Linking Brains and Brawn: Exercise and the Evolution of Human Neurobiology,” Proc. Biol. Sci. 280, № 1750 (January 2013): 201222550.

M. Moriya, C. Aoki, and K. Sakatani. “Effects of Physical Exercise on Working Memory and Prefrontal Cortex Function in Post-Stroke Patients,” Adv. Exp. Med. Biol. 923 (2016): 203–208; см. также T. Tsujii, K. Komatsu, and K. Sakatani. “Acute Effects of Physical Exercise on Prefrontal Cortex Activity in Older Adults: A Functional Near-Infrared Spectroscopy Study,” Adv. Exp. Med. Biol. 765 (2013): 293–298.

S. Dimitrov, E. Hulteng, and S. Hong. “Inflammation and Exercise: Inhibition of Monocytic Intracellular TNF Production by Acute Exercise via β2-Adrenergic Activation,” Brain Behav. Immun. 61 (March 2016): 60–68.

D. Aune et al. “Physical Activity and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis,” Eur. J. Epidemiol. 30, № 7 (July 2015): 529–542.

E. E. Hill et al. “Exercise and Circulating Cortisol Levels: The Intensity Threshold Effect,” J. Endocrinol. Invest. 31, № 7 (July 2008): 587–591.

D. E. Lieberman. “Is Exercise Really Medicine? An Evolutionary Perspective,” Curr. Sports Med. Rep. 14, № 4 (July-August 2015): 313–19; см. также D. E. Lieberman. The Story of the Human Body: Evolution, Health, and Disease (New York: Pantheon, 2013).